GOA Therapeutics Corp
Opening soonOperatingBiotech · West Palm Beach, FL
GOA Therapeutics is a preclinical biotechnology company developing GOA26, a combination of an engineered enzyme and a small molecule meant to speed ethanol clearance in acute alcohol intoxication and alcohol poisoning. It targets emergency-care patients, for whom no approved drug exists.
Not yet accepting investment.
Financials
FY2025 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Sep 15, 2026| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Preferred Stockpreferred(as of Dec 31, 2025) | 31,803,464 | 1 | 29.2% | — |
| Series Seed Preferred Stockpreferred | 12,434,816 | — | 11.4% | — |
| Common Stock | 64,566,845 | 1 | 59.3% | $15.00Sep 2026 |
| Total | 108,805,125 | 100% |
Shares outstanding over timein today's share terms
Principal holders% as the filing states it, Sep 15, 2026
- Andrew Altschuler24,869,632 Preferred Stock71.9%of Preferred
- Tami Ehrmann Barr36,270,500 Common Stock46.0%of
- Andrew Altschuler36,270,500 Common Stock46.0%of
- Scott Howell300,000 Common Stock—of
- Scott Howell0 Preferred Stock—of Preferred
- Tami Ehrmann Barr0 Preferred Stock—of Preferred
- Dean Hakanson215,000 Common Stock—of
- Dean Hakanson0 Preferred Stock—of Preferred
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
4 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
- Form 1-ASep 15, 20260001213900-26-100224EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.